Literature DB >> 24106956

Pancreatic atrophy--a new late toxic effect of sorafenib.

Ségolène Hescot, Olivier Vignaux, François Goldwasser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24106956     DOI： 10.1056/NEJMc1305302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.

Authors:  Alessandro Granito; Sara Marinelli; Giulia Negrini; Saverio Menetti; Francesca Benevento; Luigi Bolondi
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

Review 2.  Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future.

Authors:  Hwi Young Kim; Joong-Won Park
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

3.  A whole-animal platform to advance a clinical kinase inhibitor into new disease space.

Authors:  Masahiro Sonoshita; Alex P Scopton; Peter M U Ung; Matthew A Murray; Lisa Silber; Andres Y Maldonado; Alexander Real; Avner Schlessinger; Ross L Cagan; Arvin C Dar
Journal:  Nat Chem Biol       Date:  2018-01-22       Impact factor: 15.040

Review 4.  Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.

Authors:  Audrey Bellesoeur; Edith Carton; Jerome Alexandre; Francois Goldwasser; Olivier Huillard
Journal:  Drug Des Devel Ther       Date:  2017-09-21       Impact factor: 4.162

5.  Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.

Authors:  Danny Ngo; Jemianne Bautista Jia; Christopher S Green; Anjalie T Gulati; Chandana Lall
Journal:  Insights Imaging       Date:  2015-10-06

6.  Organ Atrophy Induced by Sorafenib and Sunitinib - Quantitative Computed Tomography (CT) Evaluation of the Pancreas, Thyroid Gland and Spleen.

Authors:  Hiroaki Takahashi; Katsuhiro Nasu; Manabu Minami; Takahiro Kojima; Hiroyuki Nishiyama; Toshitaka Ishiguro; Takahiro Konishi
Journal:  Pol J Radiol       Date:  2016-11-22

Review 7.  Combination therapeutics in complex diseases.

Authors:  Bing He; Cheng Lu; Guang Zheng; Xiaojuan He; Maolin Wang; Gao Chen; Ge Zhang; Aiping Lu
Journal:  J Cell Mol Med       Date:  2016-09-07       Impact factor: 5.310

8.  Sorafenib-induced Prostate Volume Reduction, a New Adverse Effect Detected by Imaging: A Pilot Study.

Authors:  Hiroaki Takahashi; Sota Masuoka; Katsuhiro Nasu; Kensaku Mori; Takahiro Kojima; Kuniaki Fukuda; Kazuhiro Takahashi; Toshitaka Ishiguro; Takahiro Hosokawa; Manabu Minami
Journal:  J Belg Soc Radiol       Date:  2018-10-26       Impact factor: 1.894

9.  A report of a new late toxic effect of lenvatinib.

Authors:  Bing Yuan; Jin-Long Zhang; Mao-Qiang Wang; Yan Wang; Jie-Yu Yan; Xiu-Qi Wang; Jin-Xin Fu
Journal:  Chin Med J (Engl)       Date:  2020-03-20       Impact factor: 2.628
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.